Table 3 Prevalence of antibiotics and antiseptics resistance genes among CoNS isolates according to its source
Antiseptic and Antibiotic Resistance Genes | Sample Source (N = 55) | P value |  | ||||
|---|---|---|---|---|---|---|---|
Environmental Samples (N = 32) | Healthcare worker (N = 14) | Clinical Infections (N = 9) |  | ||||
qac A/B | Negative | N (%) | 3(9.4) | 1(7.1) | 0 | 0.633 | |
Positive | N (%) | 29(90.6) | 13(92.9) | 9(100.0) | |||
Smr | Negative | N (%) | 25(78.1) | 2(14.3) | 6(66.7) | < 0.001* | |
| Â | Positive | N (%) | 7(21.9) | 12(85.7) | 3(33.3) | ||
qac G | Negative | N (%) | 32(100.0) | 13(92.9) | 9(92.9) | 0.225 | |
| Â | Positive | N (%) | 0 | 1(7.1) | 0 | ||
qac H | Negative | N(%) | 29(90.6) | 11(78.6) | 9(100.0) | 0.250 | |
| Â | Positive | N (%) | 3(9.4) | 3(21.4) | 0 | ||
qac J | Negative | N (%) | 32(100.0) | 11(78.6) | 8(88.9) | 0.032* | Â |
| Â | Positive | N (%) | 0 | 3(21.4) | 1(11.1) | Â | |
mecA | Negative | N (%) | 15(46.9) | 4(28.6) | 1(11.1) | 0.112 | Â |
| Â | Positive | N (%) | 17(53.1) | 10(71.4) | 8(88.9) | Â | |
mup B | Negative | N (%) | 30(93.8) | 9(64.3) | 6(66.7) | 0.025* | Â |
| Â | Positive | N (%) | 2(6.3) | 5(35.7) | 3(33.3) | Â | |
mup A | Negative | N (%) | 27(84.4) | 12(85.7) | 9(100) | 0.45 | Â |
| Â | Positive | N (%) | 5(15.6) | 2(14.3) | 0(0.0) | Â | |